Crossmark

The benefits and tolerance of exercise in myasthenia gravis (MGEX): study protocol for a randomised controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-017-2433-2

Published Online: 2018-01-18

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Birnbaum, Simone

Hogrel, Jean-Yves

Porcher, Raphael

Portero, Pierre

Clair, Bernard

Eymard, Bruno

Demeret, Sophie

Bassez, Guillaume

Gargiulo, Marcela

Louët, Estelle

Berrih-Aknin, Sonia

Jobic, Asmaa

Aegerter, Philippe

Thoumie, Philippe

Sharshar, Tarek
More Information

Article History

Received: 28 February 2017

Accepted: 27 December 2017

First Online: 18 January 2018

Authors' information

: Not applicable.

: Ethics approval for all participating centres has been provided by an ethics committee,Comité de Protection des Personnes Ile de France XI, in accordance with French regulations under the number #13064 on 13 December 2013 and authorised by theAgence National de Sécurité du Médicament et des produits de santé, reference 131300B-32, on 11 October 2013. All patients are required to provide written informed consent before inclusion in the study.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.